| __timestamp | Amphastar Pharmaceuticals, Inc. | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 51256000 | 116287000 |
| Thursday, January 1, 2015 | 77347000 | 136004000 |
| Friday, January 1, 2016 | 104189000 | 203017000 |
| Sunday, January 1, 2017 | 90795000 | 287023000 |
| Monday, January 1, 2018 | 106985000 | 393541000 |
| Tuesday, January 1, 2019 | 131923000 | 376095000 |
| Wednesday, January 1, 2020 | 143340000 | 467938000 |
| Friday, January 1, 2021 | 199739000 | 504714000 |
| Saturday, January 1, 2022 | 248860000 | 580017000 |
| Sunday, January 1, 2023 | 351121000 | 523742000 |
Data in motion
In the competitive landscape of pharmaceuticals, Supernus Pharmaceuticals, Inc. and Amphastar Pharmaceuticals, Inc. have shown remarkable growth in gross profit over the past decade. From 2014 to 2023, Supernus Pharmaceuticals has consistently outperformed Amphastar, with a gross profit increase of approximately 350%, peaking in 2022. Amphastar, while trailing, has demonstrated a robust growth trajectory, with a staggering 585% increase in the same period, culminating in 2023.
Supernus's gross profit surged from 116 million in 2014 to over 580 million in 2022, reflecting its strategic market positioning and product innovation. Meanwhile, Amphastar's gross profit rose from 51 million in 2014 to 351 million in 2023, showcasing its resilience and adaptability in a dynamic market. This analysis highlights the evolving strategies and market dynamics that have shaped these companies' financial successes.
Who Generates Higher Gross Profit? Novo Nordisk A/S or Amphastar Pharmaceuticals, Inc.
Sanofi vs Supernus Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Gross Profit Analysis: Comparing Sanofi and Amphastar Pharmaceuticals, Inc.
Takeda Pharmaceutical Company Limited vs Supernus Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Alnylam Pharmaceuticals, Inc. and Amphastar Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Incyte Corporation vs Supernus Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Walgreens Boots Alliance, Inc. vs Supernus Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Gross Profit Comparison: Ascendis Pharma A/S and Amphastar Pharmaceuticals, Inc. Trends
MorphoSys AG vs Supernus Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Who Generates Higher Gross Profit? MorphoSys AG or Amphastar Pharmaceuticals, Inc.
Cost Insights: Breaking Down Supernus Pharmaceuticals, Inc. and Amphastar Pharmaceuticals, Inc.'s Expenses
Comparing SG&A Expenses: Supernus Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc. Trends and Insights